Pancreatic Cancer Research

ResearcherChiba Cancer Center Research InstituteNo recent work listed

Takehiro Ogata

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 1 paper

Papers 3

  1. Impact of RUNX2 gene silencing on the gemcitabine sensitivity of p53‑mutated pancreatic cancer MiaPaCa‑2 spheres. Co-author DOI 10.3892/or.2018.6344↗
  2. Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 … Co-author DOI 10.1371/journal.pone.0179884↗
  3. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TA… Co-author DOI 10.18632/oncotarget.12433↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mizuyo Nakamura · 3 shared papers, 2016–2018 · strength 0.22
  2. Meijie Sang · 3 shared papers, 2016–2018 · strength 0.22
  3. Toshinori Ozaki · 3 shared papers, 2016–2018 · strength 0.22
  4. Osamu Shimozato · 3 shared papers, 2016–2018 · strength 0.22
  5. Meixiang Sang · 2 shared papers, 2016–2017 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.